Reviva Pharmaceuticals (RVPH) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

RVPH Reviva Pharmaceuticals

Watchlist

1.110
-0.040-3.48%

Trading Nov 26 11:05 ET

37.12MMarket Cap-1027P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

8-K: Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights
SECNov 14 17:31 ET
Reviva Pharmaceuticals Reports Q3 EPS (25c), Consensus (25c)
TipRanksNov 14 17:30 ET
Reviva Pharmaceuticals Reports Progress on Brilaroxazine Trials and Financial Results for Q3 2024
Quiver QuantitativeNov 14 17:30 ET
Reviva Pharm Holdings 3Q Loss/Shr 25c >RVPH
Dow JonesNov 14 17:25 ET
Reviva Pharm Holdings Is Maintained at Buy by D. Boral Capital
Dow JonesNov 14 17:25 ET · Ratings
Reviva Pharm Holdings Price Target Maintained With a $15.00/Share by D. Boral Capital
Dow JonesNov 14 17:25 ET · Ratings

Comments

Clintzilla

Nov 12 12:22

$Reviva Pharmaceuticals (RVPH.US)$ well i gave this play out a while ago anyone knows me knows i know this ticker for past few years.. nice moves today, will read and catch up on it, volume light, market conditions not great but 40% pretty good day so far.. will be on radar next year as well

Clintzilla

Sep 13 12:00

$Reviva Pharmaceuticals (RVPH.US)$ primed for a big move soon

Jaguar8

Sep 9 07:02

NEWS

$Reviva Pharmaceuticals (RVPH.US)$
Reviva Announces New Vocal Biomarker Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia
– Statistically significant vocal biomarker speech latency data reinforce the strong efficacy of brilaroxazine for negative symptoms and other key symptom domains of schizophrenia –
– Additional vocal biomarker data from ongoing open label extension study evaluating brilaroxazine in schizophrenia expected Q4 2024 –
CUPERTINO, Calif., Sept. 09, 2024 (GLOB...

Jaguar8

Aug 27 07:08

NEWS

$Reviva Pharmaceuticals (RVPH.US)$
Reviva to Host Virtual KOL Event to Discuss Vocal Biomarker Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia on September 4, 2024

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

RVPH Reviva Pharmaceuticals

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target